Piper Sandler Reiterates Overweight on Alpha Tau Medical, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has reiterated an Overweight rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a $7 price target.
August 15, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler analyst Jason Bednar has reiterated an Overweight rating on Alpha Tau Medical and maintained a $7 price target.
The reiteration of an Overweight rating and the maintenance of a $7 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100